Global Longlife Hospital and Research Ltd
Global Longlife Hospital and Research Ltd (GLHRL) last traded at ₹9.93, a market capitalisation of ₹10.4 crore. Over the past 52 weeks the stock has ranged between ₹9 and ₹26.7. Global Longlife Hospital and Research Ltd last reported results for the quarter ended Mar 2026, with sales of ₹0 crore and net profit of ₹-0.4 crore. Figures are as of 25 Aug 2026 and are not real time.
Global Longlife Hospital and Research Ltd share price and key metrics
Metrics as of 25 Aug 2026. Not real time.
Global Longlife Hospital and Research Ltd quarterly results
| ₹ crore | Sep 2022 | Mar 2023 | Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 11.8 | 11.7 | 12.33 | 1.18 | 0.58 | 0 | 0 | 0 |
| Expenses | 10.03 | 9.44 | 9.62 | 4.2 | 4.39 | 0.35 | 0.6 | 0.4 |
| Operating profit | 1.77 | 2.26 | 2.71 | -3.02 | -3.81 | -0.35 | -0.6 | -0.4 |
| OPM % | 15.00% | 19.32% | 21.98% | -255.93% | -656.90% | — | — | — |
| Other income | 0.07 | 0.17 | 0.02 | 0.04 | 5.69 | -0.67 | 0.01 | 0 |
| Interest | 0.2 | 0.2 | 0.41 | 0.36 | 0.28 | 0 | 0 | 0 |
| Depreciation | 0.58 | 0.59 | 0.61 | 0.64 | 0.48 | 0 | 0 | 0 |
| Profit before tax | 1.06 | 1.64 | 1.71 | -3.98 | 1.12 | -1.02 | -0.59 | -0.4 |
| Tax % | 29.25% | 35.37% | 39.77% | -19.10% | -11.61% | 2.94% | 123.73% | 0.00% |
| Net profit | 0.76 | 1.07 | 1.03 | -3.22 | 1.24 | -1.04 | -1.32 | -0.4 |
| EPS (₹) | 0.72 | 1.02 | 0.98 | -3.07 | 1.18 | -0.99 | -1.26 | -0.38 |
Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.
Global Longlife Hospital and Research Ltd annual results
| ₹ crore | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Sales | 32.7 | 32.44 | 23.38 | 13.46 | 0.31 | 0 |
| Operating profit | 5.44 | 8.3 | 4.08 | -0.22 | -4.14 | -1 |
| OPM % | 16.64% | 25.59% | 17.45% | -1.63% | -1,335.48% | — |
| Net profit | 2.05 | 3.57 | 1.83 | -2.19 | 0.2 | -1.72 |
| EPS (₹) | 2.93 | 5.10 | 1.74 | -2.09 | 0.19 | -1.64 |
TTM is the trailing twelve months to the most recent quarter.
Global Longlife Hospital and Research Ltd growth and returns
- 10 Years
- %
- 5 Years
- %
- 3 Years
- %
- TTM
- -100%
- 10 Years
- %
- 5 Years
- %
- 3 Years
- %
- TTM
- 63%
- 10 Years
- %
- 5 Years
- %
- 3 Years
- -38%
- 1 Year
- -54%
- 10 Years
- %
- 5 Years
- -2%
- 3 Years
- -9%
- Last Year
- -7%
Global Longlife Hospital and Research Ltd shareholding pattern
Promoters held 22.88% at Jun 2026, down from 54.90% at Jun 2025.
| % held | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 54.29% | 54.29% | 54.29% | 54.90% | 55.10% | 35.44% | 22.88% | 22.88% |
| Public | 45.73% | 45.72% | 45.70% | 45.10% | 44.91% | 64.56% | 77.11% | 77.12% |
| No. of shareholders | 974 | 989 | 938 | 917 | 915 | 985 | 1,149 | 1,133 |
As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.
Global Longlife Hospital and Research Ltd corporate filings
- Alteration in the Object Clause of Memorandum of Association of the Company.Company Updatelow impact
Cruxal's analysis: The company has initiated a process to alter the objects clause of its Memorandum of…
Read the full analysis - The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Trade Pulse Broking Pvt LtdInsider Trading / SASTmedium impact
Cruxal's analysis: Trade Pulse Broking Private Limited has acquired an additional 2 lakh 68 thousand shares…
Read the full analysis - The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Dhruv JaniInsider Trading / SASTmedium impact
Cruxal's analysis: Global Longlife Hospital and Research Limited promoter Dhruv Sureshkumar Jani has…
Read the full analysis - The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Dhruv Sureshkumar JaniInsider Trading / SASTmedium impact
Cruxal's analysis: Global Longlife Hospital and Research Limited promoter Dhruv Sureshkumar Jani has…
Read the full analysis
This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.
Track Global Longlife Hospital and Research Ltd
Cruxal reads every Global Longlife Hospital and Research Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
Cruxal publishes market data and coverage for information only. Nothing here is investment advice.